A Study of the Hexose-6-Phosphate Dehydrogenase Gene R453Q and 11β-Hydroxysteroid Dehydrogenase Type 1 Gene 83557insA Polymorphisms in the Polycystic Ovary Syndrome
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
CONTEXT: The R453Q variant in the hexose-6-phosphate dehydrogenase gene (H6PD) and 83557insA mutations in 11beta-hydroxysteroid dehydrogenase (11betaHSD) type 1 gene (HSD11B1) interact, resulting in cortisone reductase deficiency (CRD), a rare disorder characterized by a polycystic ovary syndrome (PCOS)-like phenotype. OBJECTIVE: The objective was to study these mutations in PCOS. DESIGN: The design was a case-control study. SETTING: The study was conducted in an academic hospital. PARTICIPANTS: A total of 116 PCOS patients and 76 nonhyperandrogenic controls participated. MAIN OUTCOME MEASURES: Genotype distributions and influence of genotypes on clinical and biochemical variables and, in 28 patients and 12 controls, estimates of 11betaHSD oxoreductase activity were the main outcome measures. RESULTS: Four controls and five patients presented three of four mutant alleles in H6PD R453Q and HSD11B1 83557insA, which is the genotype observed in some subjects with CRD. Estimates of 11betaHSD oxoreductase activity were measured in six of these nine women, ruling out CRD. Moreover, H6PD R453Q and HSD11B1 83557insA genotypes, either separately or in combination, did not influence 11betaHSD oxoreductase activity. The distribution of H6PD R453Q genotypes (R/R, R/Q, and Q/Q) was different in patients and controls (42% of controls and 63% of PCOS patients were R/R; 53% of controls and 31% of PCOS patients were R/Q; and 5% of controls and 6% of PCOS patients were Q/Q; chi(2) = 9.1; P = 0.011). Patients homozygous for R453 alleles presented with increased cortisol and 17-hydroxyprogesterone levels, compared with carriers of Q453 alleles, but these differences were not observed in controls. On the contrary, HSD11B1 83557insA genotypes were not associated with PCOS and did not influence any phenotypic variable. CONCLUSIONS: Digenic triallelic genotypes of the H6PD R453Q variant and HSD11B1 83557insA mutation do not always cause CRD. On the contrary, the H6PD R453Q variant is associated with PCOS and might influence its phenotype by influencing adrenal activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132 · cited 1×
“Considering that adrenal hyperactivity is a frequent finding in PCOS (17, 18), the H6PD R453Q variant may play a modifying role in the PCOS phenotype by ameliorating adrenal hyperactivity in carriers of Q453 alleles.”
Background11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque-Ramírez, M., & San Millán, J. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 422
Self-citation
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
“Polymorphisms in H6PDH may also affect risk of PCOS and cardiometabolic disease (611), plausibly through effects on 11 -HSD1 activity (e.”
BackgroundCooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
“…Tory et al. (2007) Axenfeld–Rieger syndrome FOXC1 PITX2 Kelberman et al. (2011) Cortisone reductase deficiency HSD11B1 H6PD Draper et al. (2003) and San Millán et al. (2005) Hypertrophic cardiomyopathy* MYBPC3 TNNT2 or TNNI3 or MYH7 or TPM1 Richard et al. (2003), Van Driest et al.…”
Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Nebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Cortón, M., Botella-Carretero, J. I., Benguría, A., Villuendas, G., Zaballos, A., San Millán, J. L., Escobar-Morreale, H. F., & Peral, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1665 · Cited by 175
Self-citationInhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
WALKER, B. R., & ANDREW, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 150
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Simoni, M., Tempfer, C. B., Destenaves, B., & Fauser, B. C. J. M. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn024 · Cited by 132
Family-Based Analysis of Candidate Genes for Polycystic Ovary Syndrome
Ewens, K. G., Stewart, D. R., Ankener, W., Urbanek, M., McAllister, J. M., Chen, C., Baig, K. M., Parker, S. C. J., Margulies, E. H., Legro, R. S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2703 · Cited by 110
Yazawa, T., Uesaka, M., Inaoka, Y., Mizutani, T., Sekiguchi, T., Kajitani, T., Kitano, T., Umezawa, A., & Miyamoto, K. (2008) · Endocrinology · doi:10.1210/en.2007-1015 · Cited by 95
Gambineri, A., Vicennati, V., Genghini, S., Tomassoni, F., Pagotto, U., Pasquali, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2222 · Cited by 75
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
White, P. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0942 · Cited by 47
Gambineri, A., Tomassoni, F., Munarini, A., Stimson, R. H., Mioni, R., Pagotto, U., Chapman, K. E., Andrew, R., Mantovani, V., Pasquali, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0091 · Cited by 55
Genomic variants in polycystic ovary syndrome
Luque‐Ramírez, M., Millán, J. L. S., & Escobar-Morreale, H. F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.017 · Cited by 54
Self-citationHexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism
White, P. C., Rogoff, D., McMillan, D. R., & Lavery, G. G. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.022 · Cited by 50
“A similar lack of genotype effect on 11-HSD1 activity was also reported in a small sample of PCOS patients (Millan et al., 2005), and the absence of risk for PCOS has recently been confirmed in a larger study (Draper et al., 2006).”
BackgroundThieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Isocitrate dehydrogenase: A NADPH-generating enzyme in the lumen of the endoplasmic reticulum
Margittai, É., & Bánhegyi, G. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.12.017 · Cited by 41
Goodarzi, M. O., Antoine, H. J., & Azziz, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2600 · Cited by 38
Bloom, M. S., Schisterman, E. F., & Hediger, M. L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.066 · Cited by 36
Chua, A. K., Azziz, R., & Goodarzi, M. O. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas002 · Cited by 32
Polycystic Ovary Syndrome (PCOS) and Fertility
Barbosa, G., de Sá, L. B. P. C., Rocha, D. R. T. W., & Arbex, A. K. (2016) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2016.61008 · Cited by 42
“Genomic variants in genes associated to the biosynthesis, to the regulation and action of androgens (CYP17, CP21, CP11α, 17β-HSD5, SHBG, receptor androgênico, 11β-HSD and e H6PD), to the action and secretion of insulin (INSR, VNTR, IRS-1, IRS-2, CAPN10, PPARγ, system IGF), to the secretion of gonadotropins and action…”
BackgroundInhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Svendsen, P. F., Madsbad, S., Nilas, L., Paulsen, S. K., & Pedersen, S. B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.165 · Cited by 33
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 75
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Smit, P., Dekker, M. J. H. J., de Jong, F. J., van den Beld, A. W., Koper, J. W., Pols, H. A. P., Brinkmann, A. O., de Jong, F. H., Breteler, M. M. B., & Lamberts, S. W. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1349 · Cited by 26
Draper, N., Powell, B. L., Franks, S., Conway, G. S., Stewart, P. M., & McCarthy, M. I. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02547.x · Cited by 27
Valkenburg, O., Uitterlinden, A. G., Themmen, A. P. N., de Jong, F. H., Albert Hofman, D., Fauser, B. C. J. M., & Laven, J. S. E. (2011) · Human Reproduction · doi:10.1093/humrep/der222 · Cited by 26
“While the H6PD variant was associated with disease risk and the presence of increased levels of cortisol and 17-hydroxyprogesterone in one study (San Millan et al., 2005), this finding was not confirmed by the others.”
BackgroundResultFeldman, K., Szappanos, Á., Butz, H., Grolmusz, V. K., Majnik, J., Likó, I., Kriszt, B., Lakatos, P. L., Tóth, M., Rácz, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.014 · Cited by 25
“In addition, several associations between InsA polymorphism and various diseases were reported, but the results obtained in different populations were partly contradictory [9,15,16].”
Gourgari, E., Lodish, M. B., Keil, M. F., Sinaii, N., Turkbey, E. B., Lyssikatos, C., Nesterova, M., Sierra, M. D. L. L., Xekouki, P., Khurana, D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4019 · Cited by 21
Tureck, L. V., Leite, N., de Souza, R. L. R., Lima, J. K., Milano, G. E., Timossi, L. D. S., Osiecki, A. C. V., Osiecki, R., & Alle, L. F. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000400003 · Cited by 21
“Other studies found no relationship be- tween one or both variants and 11 -HSD1 levels (Nair et al., 2004; Millan et al., 2005; White, 2005; Malavasi et al., 2010).”
BackgroundPhysiological roles of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase
White, P. C., Rogoff, D., & McMillan, D. R. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328305e439 · Cited by 16
Dujić, T., Bego, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., & Čaušević, A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.008 · Cited by 16
“HbA1c (mmol/mol) 43 (37-55) 38 (29-42) <0.”
BackgroundMartínez-García, M. Á., San‐Millán, J. L., & Escobar-Morreale, H. F. (2012) · Gene · doi:10.1016/j.gene.2012.01.047 · Cited by 16
Self-citationHydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review
Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 23
“Recently, the functional consequences in these polymorphisms in HSD11B1 gene were examined and the results confirm previous reports that the variant in HSD11B1 confer increased 11β-HSD1 expression and activity, that are associated with the metabolic syndrome [183, 185] but are not associated with the prevalence of PCO…”
BackgroundResultMoon, S., Lee, Y.-S., Kim, J.-G., Kim, S.-W., Jeong, J.-Y., Jeon, E.-J., Seo, H.-A., Kwak, S. H., Park, K. S., & Lee, I. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0035 · Cited by 15
Gandhi, K. R., Adhikari, P., Basu, A., & Achappa, B. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0049 · Cited by 14
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Szappanos, Á., Patócs, A., Gergics, P., Bertalan, R. Á., Kerti, A., Ács, B., Feldman, K., Rácz, K., & Tóth, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.009 · Cited by 14
Escobar-Morreale, H. F., Insenser, M. R., Cortón, M., Millán, J. L. S., & Peral, B. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780031 · Cited by 12
“Many genetic polymorphisms associated with PCOS or its phenotypic variables have been reported, including a 50UTR repeat polymorphism in CYP11A that is positively associated with PCOS and serum testosterone levels [28], the hexose-6-phosphate dehydrogenase gene R453Q polymorphism [29], a common interleukin-6 gene prom…”
Self-citationQin, K., & Rosenfield, R. L. (2010) · Steroids · doi:10.1016/j.steroids.2010.10.001 · Cited by 13
Androgens and polycystic ovary syndrome
Alpañés, M., Fernández‐Durán, E., & Escobar-Morreale, H. F. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.85 · Cited by 17
Self-citationMorales, M., Carvajal, C. A., Ortiz, E., Mosso, L. M., Artigas, R., Owen, G. I., & Fardella, C. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000600003 · Cited by 12
Devang, N., Satyamoorthy, K., Rai, P. S., Nandini, M., Basu, A., & Adhikari, P. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0596-8 · Cited by 9
“on the Dallas residents did not show any association of HSD11B1 variants with PCOS [26, 27].”
BackgroundJu, R., Wu, W., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140326 · Cited by 7
“Although previous genetic studies reported a significant association between H6PD polymorphisms and the phenotype of PCOS [10, 22, 23], a case-control study in 2011 using DNA samples from 74 patients with PCOS and 31 healthy controls indicated that the H6PD gene coding variants rarely (<1.”
ResultMoon, S., Lee, Y., Kim, J., & Lee, I. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.020 · Cited by 8
Tamaoka, S., Saito, K., Yoshida, T., Nakabayashi, K., Tatsumi, K., Kawamura, T., Matsuzaki, T., Matsubara, K., Ogata‐Kawata, H., Hata, K., et al. (2023) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12504 · Cited by 6
Importance of the 11β-hydroxysteroid dehydrogenase enzyme in clinical disorders
Feldman, K., Likó, I., Nagy, Z., Szappanos, Á., Grolmusz, V. K., Tóth, M., Rácz, K., & Patócs, A. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29558 · Cited by 5
Goodarzi, M. O. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_3 · Cited by 4
Glucocorticoid Metabolism and Activation
Othonos, N., & Tomlinson, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64302-7 · Cited by 4
Goodarzi, M. O., Antoine, H. J., & Azziz, R. (2007) · Cited by 3
A review of hyperandrogenism state in polycystic ovarian syndrome
Mohamed Shabi, M., Nivya, P. S., Devika, C., Reddy, M. S., Poornima, N., R., R. K., Joseph, J., & Kolageri, S. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20233666 · Cited by 3
ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance
Uncu, G., Özyürek, E. Ş., & Uncu, Y. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.011 · Cited by 2
Naseri, R., Alimoradi, Y., Sohrabi, M., Fard, M. C., Barzingarosi, E., Abdolmaleki, A., & Jalili, C. (2022) · PubMed Central · doi:10.22074/ijfs.2021.141690.1050 · Cited by 1
11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Stimson, R. H., & Walker, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_10 · Cited by 1
Bánhegyi, G., Benedetti, A., & Csala, M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb152 · Cited by 1
Genetic Analyses of Polycystic Ovary Syndrome
Urbanek, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_5
Marunych, R. Y. (2013) · Biopolymers and Cell · doi:10.7124/bc.00080d
“There are many known pathologies, related to the states of this enzyme deficiency and its various mutations, including neonatal jaundice [43], impairment of -cells in conditions of high glucose content at diabetes [44], chronic erythrolysis and megalocytic anemia [45], polycyctic ovarian disease [46], etc.”
Glucocorticoid metabolism and activation
Othonos, N., & Tomlinson, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00210-7
Genetics of Metabolic Syndrome and Genetic Lipodystrophies
JOY, T. R., & Hegele, R. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_5
Metadata
- Authors
- San Millán, J. L., Botella-Carretero, J. I., Álvarez-Blasco, F., Luque-Ramírez, M., Sancho, J., Moghetti, P., & Escobar-Morreale, H. F.
- Affiliations
- University of Verona (IT)
- Corresponding author
- Escobar-Morreale, Héctor F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07
- Volume
- 90
- Issue
- 7
- Pages
- 4157-4162
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2028513159
- Semantic Scholar
- b7cea3c919031cd8d6ff122da996179c60545d7a
- Cited by
- 65
- References
- 19
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 7 · 2012: 5
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Comunidad de Madrid
- Instituto de Salud Carlos III (RGDM G03/212)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- polycystic ovary syndrome, hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, cortisol, 17-hydroxyprogesterone, hyperandrogenism, genetic polymorphism
- MeSH terms
- Adult, Carbohydrate Dehydrogenases, Cortisone Reductase, Female, Genotype, Humans, Polycystic Ovary Syndrome, Polymorphism, Genetic, Case-Control Studies, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.